ITGB3BP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.693800E-01
Normal-vs-Stage2
4.611800E-01
Normal-vs-Stage3
2.475600E-01
Normal-vs-Stage4
3.317200E-01
Stage1-vs-Stage2
9.113400E-01
Stage1-vs-Stage3
4.143600E-01
Stage1-vs-Stage4
7.144600E-01
Stage2-vs-Stage3
2.303800E-01
Stage2-vs-Stage4
6.767800E-01
Stage3-vs-Stage4
5.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.395600E-01
Normal-vs-AfricanAmerican
6.425500E-02
Normal-vs-Asian
8.348000E-02
Caucasian-vs-AfricanAmerican
6.805800E-02
Caucasian-vs-Asian
1.152450E-01
AfricanAmerican-vs-Asian
3.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.985200E-01
Normal-vs-Female
5.581400E-01
Male-vs-Female
5.091200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.193000E-01
Normal-vs-Age(41-60Yrs)
7.063800E-01
Normal-vs-Age(61-80Yrs)
3.701600E-01
Normal-vs-Age(81-100Yrs)
5.281200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.258200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.425400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.083200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.230350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.353800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.456200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.853200E-01
Normal-vs-Daily Drinker
3.935600E-01
Normal-vs-Weekly Drinker
5.403000E-01
Normal-vs-Occasional Drinker
6.207200E-01
Normal-vs-Social Drinker
7.237400E-01
Non Drinker-vs-Daily Drinker
7.584200E-01
Non Drinker-vs-Weekly Drinker
9.599400E-01
Non Drinker-vs-Occasional Drinker
3.580600E-01
Non Drinker-vs-Social Drinker
2.689000E-01
Daily Drinker-vs-Weekly Drinker
8.150800E-01
Daily Drinker-vs-Occasional Drinker
4.980400E-01
Daily Drinker-vs-Social Drinker
3.632400E-01
Weekly Drinker-vs-Occasional Drinker
5.222400E-01
Weekly Drinker-vs-Social Drinker
4.169800E-01
Occasional Drinker-vs-Social Drinker
8.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.561000E-01
Normal-vs-Grade 2
8.139400E-01
Normal-vs-Grade 3
7.913400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.613900E-02
Grade 1-vs-Grade 3
2.993200E-01
Grade 1-vs-Grade 4
7.561000E-01
Grade 2-vs-Grade 3
3.962000E-01
Grade 2-vs-Grade 4
8.139400E-01
Grade 3-vs-Grade 4
7.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.871820E-01
Normal-vs-NonDiabetic
5.066600E-01
Diabetic-vs-NonDiabetic
5.696200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.544200E-01
Normal-vs-NoPancreatitis
4.344400E-01
Pancreatitis-vs-NoPancreatitis
6.152400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.242600E-01
Normal-vs-N1
4.507000E-01
N0-vs-N1
3.396200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.065200E-01
Normal-vs-TP53-NonMutant
8.129000E-01
TP53-Mutant-vs-TP53-NonMutant
1.020390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
